Cited by 100Atrial Fibrillation Management and OutcomesAcute Ischemic Stroke ManagementHealth Promotion and Cardiovascular Prevention

Population screening of 75- and 76-year-old men and women for silent atrial fibrillation (STROKESTOP)

Open access
Friberg, Leif, Engdahl, Johan, Frykman, Viveka, Svennberg, Emma, Levin, Lars-Åke, Rosenqvist, Mårten·2013·EP Europace

Abstract

Atrial fibrillation (AF) is important because it is common and is a major cause of stroke unless treated with oral anticoagulant. The prevalence of AF increases with age as does the risk of stroke. At 75 years the risk from age alone is so high that current guidelines recommend anticoagulation even in the absence of other risk factors. Atrial fibrillation is often asymptomatic and only discovered by chance or when a stroke already has occurred. We have launched a major screening study for silent AF in which 25,000 Swedes aged 75 and 76 years are randomized to either participate in a screening programme using ambulant intermittent electrocardiogram (ECG) recording to detect silent AF, or act as a control group. Patients in whom AF is detected are offered cardiological examination and anticoagulant treatment according to current guidelines. The cohort and the controls will be followed prospectively for 5 years after the inclusion of the first participant. An interim analysis will be made after 3 years. Our hypothesis is that screening for AF will reduce stroke incidence in the screened population, and that this screening will prove to be cost effective. Secondary endpoints are: any thromboembolic event, intracranial bleeding, other major bleeding, first ever diagnosis of dementia, death from any cause, and a composite of these endpoints.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/europace/eus217

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • There is good evidence that prolonged ECG monitoring enhances the detection of undiagnosed AF, for 72 hours after a stroke, for even longer periods, or by daily short-term ECG recording in patients over 75 years of age.

    “There is good evidence that prolonged ECG monitoring enhances the detection of undiagnosed AF, for 72 hours after a stroke, 27,127 for even longer periods, 18,128 or by daily short-term ECG recording in patients over 75 years of age 129 (Web Addenda Figure 1).”
  • The true prevalence of AF is likely substantially higher than the estimated prevalence because many individuals remain undiagnosed.

    “The true prevalence is likely to be substantially higher given that many individuals remain undiagnosed.2”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Gold M, Hohnloser S, Connolly S, Israel C, Morillo C, Chu-Pak L et al. Relationship between duration of pacemaker-detected atrial tachyarrhthmias and stroke or embolus: insights from the ASSERT trial (Abstract). Heart Rhytm 2012;9:s24.

Cited by

Sorted by citations

Authors
Friberg, L., Engdahl, J., Frykman, V., Svennberg, E., Levin, L.-Å., & Rosenqvist, M.
Affiliations
  • Danderyds sjukhus (SE)
  • Hallands sjukhus Halmstad (SE)
  • Linköping University (SE)
  • Karolinska Institutet (SE)
Corresponding author
Friberg, Leif
Venue
EP Europace
Published
2012-07-11
Volume
15
Issue
1
Pages
135-140
ISSN
  • 1099-5129 (ISSN-L)
  • 1532-2092
OpenAlex
W2019334626
Cited by
100
References
44
Citations by year
2025: 3 · 2024: 6 · 2023: 4 · 2022: 5 · 2021: 6 · 2020: 4 · 2019: 8 · 2018: 11 · 2017: 9 · 2016: 13 · 2015: 14 · 2014: 9 · 2013: 4 · 2012: 3
FWCI
6.17
Type
journal article
Language
en
Open access
Locations
  • EP Europace (publishedVersion)
  • PubMed (publishedVersion)
Funders
Stockholms Läns Landsting
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
  • Health Sciences › Medicine › Epidemiology › Acute Ischemic Stroke Management
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
Keywords
silent atrial fibrillation, atrial fibrillation screening, stroke prevention, oral anticoagulation, older adults, thromboembolic events, intracranial hemorrhage, dementia, cost-effectiveness
MeSH terms
Aged, Atrial Fibrillation, Electrocardiography, Female, Humans, Male, Mass Screening, Registries, Risk Factors, Sweden, Comorbidity, Incidence, Stroke, Early Diagnosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review